Aceragen Q1 Earnings Snapshot
| ACGNDelisted Stock | 0.75 0.23 23.47% |
About 62% of Aceragen's investor base is looking to short. The analysis of current outlook of investing in Aceragen suggests that many traders are alarmed regarding Aceragen's prospects. Aceragen's investing sentiment overview a quick insight into current market opportunities from investing in Aceragen. Many technical investors use Aceragen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aceragen |
EXTON, Pa. AP Aceragen, Inc. ACGN on Thursday reported a first-quarter loss of 21.9 million, after reporting a profit in the same period a year earlier.
Read at finance.yahoo.com
 |
Aceragen Fundamental Analysis
We analyze Aceragen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aceragen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aceragen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Aceragen is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Aceragen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aceragen stock to make a market-neutral strategy. Peer analysis of Aceragen could also be used in its relative valuation, which is a method of valuing Aceragen by comparing valuation metrics with similar companies.
Peers
Aceragen Related Equities
| PCSA | Processa Pharmaceuticals | 18.37 | ||||
| IBIO | Ibio | 11.79 | ||||
| ACXP | Acurx Pharmaceuticals | 8.70 | ||||
| AKTX | Akari Therapeutics | 8.04 | ||||
| ATXI | Avenue Therapeutics | 4.37 | ||||
| QNRX | Quoin Pharmaceuticals | 1.69 | ||||
| ADXN | Addex Therapeutics | 1.04 | ||||
| SNTI | Senti Biosciences | 0.93 | ||||
| ACRV | Acrivon Therapeutics, | 0.80 | ||||
| RNXT | RenovoRx | 0.79 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
| SNGX | Soligenix | 0.60 | ||||
| SABS | SAB Biotherapeutics | 1.02 | ||||
| TPST | Tempest Therapeutics | 1.04 | ||||
| COCP | Cocrystal Pharma | 1.43 | ||||
| ARMP | Armata Pharmaceuticals | 2.13 | ||||
| BPTH | Bio Path | 3.75 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Aceragen Stock
If you are still planning to invest in Aceragen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aceragen's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |